959 results on '"Lauria, Francesco"'
Search Results
2. Mucocele of the appendix: case report of a rare disease with changing diagnostic-therapeutic behavior
3. Telemedicine During COVID-19 Pandemic: Lesson Learned from the Lazio Region Infectious Diseases and Emergency Department Network
4. Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia
5. Hairy cell leukemia and COVID-19 adaptation of treatment guidelines
6. Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis of a randomised phase 3, open-label study
7. Collectivising services: a path to trade union renewal in Europe
8. Multi-omics approach to COVID-19: a domain-based literature review
9. The Sydney metro Skytrain cable stayed bridge
10. Looking for pathways related to COVID-19: confirmation of pathogenic mechanisms by SARS-CoV-2–host interactome
11. Tuberculin skin test – Outdated or still useful for Latent TB infection screening?
12. Enabling Rapid Response to the 2014–2016 Ebola Epidemic: The Experience and the Results of the National Institute for Infectious Diseases Lazzaro Spallanzani
13. Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia
14. Collectivising services: a path to trade union renewal in Europe.
15. Hairy cell leukemia variant and WHO classification correspondence Re: 5thedition WHO classification haematolymphoid tumors: lymphoid neoplasms
16. Long-term efficacy and toxicity of rituximab plus fludarabine and mitoxantrone (R-FM) for gastric marginal zone lymphoma: a single-center experience and literature review
17. Supplementary Tables S1-S4 from The Prognostic Value of TP53 Mutations in Chronic Lymphocytic Leukemia Is Independent of Del17p13: Implications for Overall Survival and Chemorefractoriness
18. Chemoimmunotherapy with oral low-dose fludarabine, cyclophosphamide and rituximab (old-FCR) as treatment for elderly patients with chronic lymphocytic leukaemia
19. Increasing the Biological Inspiration of Neural Networks
20. SIE, SIES, GITMO updated clinical recommendations for the management of chronic lymphocytic leukemia
21. Enabling Rapid Response to the 2014–2016 Ebola Epidemic: The Experience and the Results of the National Institute for Infectious Diseases Lazzaro Spallanzani
22. Break up to Get Back Together: The Impact of Unionisation Through Innovative Service Provision on Union Membership and Industrial Relations. Comparative Report
23. Break up to get back together: l’impatto dei servizi innovativi sulla membership sindacale e le relazioni industriali. Rapporto nazionale: Italia
24. Break up to Get Back Together: The Impact of Unionisation Through Innovative Service Provision on Union Membership and Industrial Relations. Country Report: Italy
25. Association of Profoundly Impaired Immune Competence in H1N1v-Infected Patients with a Severe or Fatal Clinical Course
26. The host genetic background of DNA repair mechanisms is an independent predictor of survival in diffuse large B-cell lymphoma
27. Impaired expression of p66Shc, a novel regulator of B-cell survival, in chronic lymphocytic leukemia
28. Weekly Bortezomib, Pegylated Liposomal Doxorubicin, and Dexamethasone Is a Safe and Effective Therapy for Elderly Patients With Relapsed/Refractory Multiple Myeloma
29. Consensus document on controversial issues for the treatment of infections of the central nervous system: bacterial brain abscesses
30. Consensus document on controversial issues for the treatment of hospital-associated pneumonia
31. Consensus document on controversial issues in the diagnosis and treatment of prosthetic joint infections
32. Consensus document on controversial issues in the treatment of complicated skin and skin-structure infections
33. Consensus document on controversial issues in the diagnosis and treatment of bloodstream infections and endocarditis
34. Resistant and multi-resistant Gram-positive severe infections: the GISIG working methodology
35. Methicillin-resistant Staphylococcus aureus: the superbug
36. Hairy cell leukemias with unmutated IGHV genes define the minor subset refractory to single-agent cladribine and with more aggressive behavior
37. Additional file 1 of Multi-omics approach to COVID-19: a domain-based literature review
38. The Effects of Zoledronic Acid on Serum Lipids in Multiple Myeloma Patients
39. Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia
40. Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis of a randomised phase 3, open-label study
41. Lessons from the COVID-19 Pandemic—Unique Opportunities for Unifying, Revamping and Reshaping Epidemic Preparedness of Europe’s Public Health Systems
42. Cost of illness in patients with multiple myeloma in Italy: the CoMiM study
43. Evaluation of residual CD34+Ph+ progenitor cells in chronic myeloid leukemia patients who have complete cytogenetic response during first-line nilotinib therapy
44. Extramedullary intracranial localization of multiple myeloma and treatment with novel agents: A retrospective survey of 50 patients
45. A pilot monocentric analysis of efficacy and safety of Fludarabine-Campath combination (Flucam) as first line treatment in elderly patients with chronic lymphocytic leukaemia and Tp53 disfunction
46. NarrAzioni in rete. Riflessioni e processi a partire da.
47. Oxaliplatin-based chemotherapy (dexamethasone, high-dose cytarabine, and oxaliplatin) ± rituximab is an effective salvage regimen in patients with relapsed or refractory lymphoma
48. Complete molecular response in CML after p210 BCR-ABL1-derived peptide vaccination
49. Hyperlipidemic myeloma
50. Predicting the clinical course of Hodgkin lymphoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.